INTP.PK on USA Pink Sheets
0.00USD
9 Feb 2010
0.00USD
9 Feb 2010
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$0.00
$0.00
Open
$0.00
$0.00
Day's High
$0.00
$0.00
Day's Low
$0.00
$0.00
Volume
51,588
51,588
Avg. Vol
79,640
79,640
52-wk High
$0.02
$0.02
52-wk Low
$0.00
$0.00
Revenue
| Periods | 2006 | 2007 | 2008 |
|---|---|---|---|
| March | 0.047 | 0.0 | 0.0 |
| June | 0.014 | 0.0080 | 0.0 |
| September | 0.0 | 0.027 | |
| December | 0.0 | 0.035 | |
| Totals | 0.061 | 0.035 |
Note: Units in Millions of U.S. Dollars
Earnings Per Share
| Periods | 2006 | 2007 | 2008 |
|---|---|---|---|
| March | -0.02896 | -0.0123 | -0.00884 |
| June | -0.02145 | -0.01165 | -0.00985 |
| September | -0.02226 | -0.00808 | |
| December | -0.01991 | -0.04474 | |
| Totals | -0.0932 | -0.04474 |
Note: Units in U.S. Dollars
Consensus Estimates Analysis
No consensus analysis data available.
Sales and Earnings Figures in U.S. Dollars (USD)
Valuation Ratios
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 11.50 | 3.76 | 14.59 |
| P/E High - Last 5 Yrs. | NA | 6.38 | 1.59 | 16.18 |
| P/E Low - Last 5 Yrs. | NA | 2.77 | 0.55 | 4.36 |
| Beta | -- | 0.65 | 0.65 | 1.33 |
| Price to Sales (TTM) | 4.36 | 29.11 | 1.22 | 2.01 |
| Price to Book (MRQ) | 0.20 | 3.61 | 1.99 | 2.58 |
| Price to Tangible Book (MRQ) | 0.24 | 18.26 | 3.19 | 5.66 |
| Price to Cash Flow (TTM) | -- | 6.76 | 2.07 | 7.12 |
| Price to Free Cash Flow (TTM) | -- | 15.28 | 24.92 | 12.79 |
| % Owned Institutions | -- | -- | -- | -- |
Dividends
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Dividend Yield | NA | 0.02 | 0.29 | 1.71 |
| Dividend Yield - 5 Year Avg. | -- | 0.02 | 1.60 | 2.35 |
| Dividend 5 Year Growth Rate | -- | 0.31 | 15.63 | -5.31 |
| Payout Ratio(TTM) | -- | 0.75 | 4.46 | 24.71 |
Growth Rates
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -100.00 | 78.04 | 6.84 | 10.73 |
| Sales (TTM) vs TTM 1 Yr. Ago | 237.50 | 20.75 | 1.90 | -4.74 |
| Sales - 5 Yr. Growth Rate | -- | 20.82 | 8.05 | 7.42 |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 15.45 | 95.58 | 142.38 | 98.28 |
| EPS (TTM) vs TTM 1 Yr. Ago | 40.29 | -- | -- | -- |
| EPS - 5 Yr. Growth Rate | -- | 16.65 | 5.61 | 8.85 |
| Capital Spending - 5 Yr. Growth Rate | -- | 3.87 | 6.95 | 5.91 |
Financial Strength
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Quick Ratio (MRQ) | 0.70 | 5.80 | 2.57 | 0.81 |
| Current Ratio (MRQ) | 1.00 | 6.27 | 3.05 | 0.95 |
| LT Debt to Equity (MRQ) | 0.00 | 22.84 | 25.13 | 127.01 |
| Total Debt to Equity (MRQ) | 0.00 | 26.92 | 32.96 | 179.52 |
| Interest Coverage (TTM) | -225.00 | 46.19 | 3.69 | 11.83 |
Profitability Ratios
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Gross Margin (TTM) | 85.19 | 41.84 | 12.78 | 31.64 |
| Gross Margin - 5 Yr. Avg. | -- | 56.10 | 56.69 | 29.11 |
| EBITD Margin (TTM) | -4,248.15 | -- | -- | -- |
| EBITD - 5 Yr. Avg | -- | -149.46 | 16.23 | 15.13 |
| Operating Margin (TTM) | -6,277.78 | -392.08 | -4.90 | -- |
| Operating Margin - 5 Yr. Avg. | -- | -173.30 | 12.24 | 17.30 |
| Pre-Tax Margin (TTM) | -6,303.70 | -395.84 | -4.88 | 12.47 |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -166.39 | 14.23 | 16.97 |
| Net Profit Margin (TTM) | -6,303.70 | -397.60 | -5.71 | 9.80 |
| Net Profit Margin - 5 Yr. Avg. | -- | -168.72 | 7.73 | 12.33 |
| Effective Tax Rate (TTM) | -- | 8.43 | 3.58 | 14.83 |
| Effecitve Tax Rate - 5 Yr. Avg. | -- | 25.73 | 34.40 | 26.46 |
Efficiency
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 244,231 | 1,282,917 | 299,091 |
| Net Income/Employee (TTM) | -- | -162,605 | 213,959 | 26,863 |
| Receivable Turnover (TTM) | 54.00 | 3.23 | 0.89 | 8.07 |
| Inventory Turnover (TTM) | 0.04 | 1.33 | 0.64 | 5.03 |
| Asset Turnover (TTM) | 0.02 | 0.26 | 0.12 | 0.44 |
Management Effectiveness
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Return on Assets (TTM) | -136.76 | 1.57 | 1.78 | 4.25 |
| Return on Assets - 5 Yr. Avg. | -- | -3.15 | 6.74 | 4.83 |
| Return on Investment (TTM) | -190.70 | 1.25 | 2.30 | 5.67 |
| Return on Investment - 5 Yr. Avg. | -- | -3.49 | 8.69 | 6.33 |
| Return on Equity (TTM) | -190.70 | 2.09 | 2.82 | 12.56 |
| Return on Equity - 5 Yr. Avg. | -- | -5.89 | 10.04 | 12.84 |
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Sales % | -42.62 | -- | -- |
| EPS % | 52.00 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Integrated Pharmaceuticals, Inc.
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 0 |
| Total Shares Held: | 0 |
| 3 Mo. Net Change: | 0 |
| # New Positions: | 0 |
| # Closed Positions: | 0 |
| # Increased Positions: | 0 |
| # Reduced Positions: | 0 |
| # Net Buyers: | 0 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.





